期刊文献+

纤维化淤胆性肝炎肝组织α-SMA及Ⅰ、Ⅲ型胶原的表达 被引量:1

Expressions of α-smooth muscle actin and collagen type Ⅰ,Ⅲ in biopsy liver tissue from patients with fibrosing cholestatic hepatitis
下载PDF
导出
摘要 目的了解纤维化淤胆性肝炎(FCH)肝星状细胞(HSC)活化状态及其与肝纤维化的关系。方法肾移植术后乙型肝炎病毒(HBV)相关性FCH患者9例,正常者5例作为对照。用免疫组织化学的方法检测肝组织α-平滑肌肌动蛋白(α-SMA)及Ⅰ、Ⅲ型胶原蛋白的表达。结果FCH肝组织α-SMA与Ⅰ、Ⅲ型胶原蛋白表达显著增加,表达分布部位一致,定量分析呈明显正相关(P<0.01)。结论肾移植术后HBV相关性FCH患者肝纤维化的发生与HSC的活化状态有关。 Objective To observe expressions of α - smooth muscle actin(α - SMA) and collagen type Ⅰ ,Ⅲ deposition in the liver tissues, and to evaluate potential mechanism of fibrosis in patients with fibrosing cholestatic hepatitis (FCH) by collagen synthesis. Method Immunohistochemical staining was used to detect the expressions of α - SMA and contents of type Ⅰ ,Ⅲ collagen proteins, which were from the specimens of the biopsy liver in 9 cases with FCH associated with hepatitis virus B (HBV) developed following renal transplantation and in 5 cases without liver disease( control group) , respectively. Results The expressions of α - SMA and type Ⅰ , Ⅲ collagen proteins in the patients with FCH were significantly higher than those in the control group. The expression and distribution pattern of α - SMA and type Ⅰ , Ⅲ collagen proteins were almost identical, and quantitative analysis showed a positive correlation ( P 〈 0. 01 ). Condusion The state of hepatic stellate cell (HSC) activation may contribute to hepatic fibrosis in the patients with FCH.
出处 《中国医师进修杂志(内科版)》 2006年第12期21-22,共2页 Chinese Journal of Postgraduates of Medicine
关键词 纤维化淤胆性肝炎 肝星状细胞 Ⅰ型胶原 Ⅲ型胶原 Fibrosing cholestatic hepatitis Hepatic stellate cell Collagen type Ⅰ Collagen type Ⅲ
  • 相关文献

参考文献3

  • 1Davies SE,Portmann BC,O'Grady JG,et al.Hepatic histological findings after transplantation for chronic hepatitis B virus infection,including a unique pattern of fibrosing cholestatic hepatitis.Hepatology,1991,13(1):150-157
  • 2王欣欣,郎振为,孟忻,孙琳,王泰龄,赵景民,张世杰.α-SMA在慢性乙型病毒性肝炎肝组织中的表达[J].临床肝胆病杂志,2005,21(2):76-78. 被引量:9
  • 3Russo MW,Firpi RJ,Nelson DR,et al.Early hepatic stellate cell activation is associated with advanced fibrosis after liver transplantation in recipients with hepatitis C.Liver Transpl,2005,11 (10):1235-1241.

二级参考文献12

  • 1Levy MT, McCaughan GW, Marinos G, et al. Intrahepatic expression of the hepatic stellate cell marker fibroblast activation protein correlates with the degree of fibrosis in hepatitis C virus infection [ J ]. Liver, 2002,22:93 -101.
  • 2Takuya Kitada, Shuichi Seki, Kazuo IKeda, et al. Clinicopathological characterization of prion: a novel marker of activated human hepatic stellate cells[ J ]. J Hepatolo, 2000,33: 751 - 757.
  • 3Schmitt - Graff A, Kruger S, Bochard G, et al. Modulation of alpha smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased human livers[J]. Am J Pathol, 1991,138:1233 - 1242.
  • 4Yamaoka K, Nouchi T, Marumo F. Alpha- smooth- muscle actin express in normal and fibrotic human livers[J]. Dig Sci, 1993,38(8): 1473 -1479.
  • 5Zeiberg M, Strutz F, Muller GA, et al. Role of fibroblast activation in inducing interstitial fibrosis[J] .J Nephrol,2000,13(suppl 3):S111 - 120.
  • 6Khan M A, Poulos J E, Brunt E M, et al. Hepatic alpha- smooth muscle actin expression in hepatitis C patients before and after interferon therapy [J]. Hepatogastroenterology, 2001,48(37) :212 - 215.
  • 7Clouston A D Jonsson J R, Purdie D M, et al. Steatosis and chronic hepatitis C: analysis of fibrosis and stellate cell activation[ J]. J Hepatol, 2001,34(2) :314 - 320.
  • 8Utsunomiya Y, Kawamura T, Abe A, et al. Significance of mesangial expression of alphasmooth muscle actin in the progression of IgA nephropathy[J] .AM J kidney Dis, 1999,34:902 - 910.
  • 9Phan SH. Role of the myofibroblsat in pulmonary fibrosis[J]. Kidney Int,1996,49( suppl54 ): S46 - 48.
  • 10Svegliati Baroni G, Patorelli A, Manzin A, et al. Hepatic stellate cell activation and liver fibrosis are associated with necroinflammatory injury and Th1-like response in chronic hepatitis C[J]. Liver, 1999, 19:212-219.

共引文献8

同被引文献8

  • 1陈灏珠.实用内科学[M]12版.北京:人民卫生出版社,2005.1746-1750.
  • 2王文革,钱云良,商庆新.细胞因子与瘢痕形成机制的研究进展[J].中华整形烧伤外科杂志,1997,13(2):128-130. 被引量:21
  • 3Martine Apikian,Greg Goodman.Intralesional 5-fluorouracil in the treatment of keloid scars[J].Aust J Dermatol,2004,45(2):140-143.
  • 4Teirstein PS,Massullo Y,Jani S,et al.Three-year clinical and an- giographic follow-up after intracoronary radication:results of a ran- domized clinical trial[J].Circulation,2000,101:360-365.
  • 5Iwakiri R.NSAIDs and its gastrointestinal side effects:relation of NSAIDs variety and influence of concomitant medicine[J].Nippon Rinsho,2007,65:1776.
  • 6Wendling,Marchand A,Mauviel A,et al.5-Fluorouracil Blocks Transforming Growth Factor-P-Induced a2 Type I Collagen Gene (C0L1A2)Expression in Human Fibroblasts via c-Jun NH2-Termi- nal Kinase_Activator Protein-1 Activation[J].Mol Pharmacol,2003,64(3):707-713.
  • 7邹浩,王滔,张小文,朱红,纳钊,沈需.人良性胆管瘢痕成纤维细胞的培养和鉴定[J].基础医学与临床,2011,31(6):719-720. 被引量:2
  • 8黄辉,唐胜建,鲍卫汉.α-平滑肌肌动蛋白在瘢痕成纤维细胞中的表达[J].中国修复重建外科杂志,2001,15(6):347-350. 被引量:11

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部